The Korlym has received FDA approval for patients with endogenous Cushing’s syndrome.
PharmaForm is a full-service contract provider of development and manufacturing for the pharmaceutical and biotech industry.
PharmaForm has worked with Corcept for several years as a contract provider for services in the development, optimization and validation of the manufacturing process for Corcept’s Korlym.